Global Clinical Site Accreditation (GCSA) has launched with a commitment aimed at increasing clinical research and trial capacity and quality in the UK, as well as globally. GCSA awards a certification mark through an evidence-based approach.
“As a global clinical research organization, Parexel is focused on working with sites as a partner in the clinical development process,” said Agnieszka Gackowska, Senior Director, Global Site Solutions. “To this end, the ability to pivot in pandemic situations and conduct trials in potentially unpredictable situations—implementing new approaches like decentralized clinical trials—is key...as we work together to bring new therapies to patients in need.”
GCSA is an assessment, improvement, and accreditation organization. A collaboration between Future Shaping Holdings Ltd, the parent company of IAOCR, and Develop Consulting.
For more information, click here.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.